CLINICAL_TRIALS
trial_result
· 2021-10-13
Clinical Trial Update: Fluoxetine for Visual Recovery After Ischemic Stroke [Phase 2]
Summary
Phase 2 trial updating on fluoxetine for visual recovery after ischemic stroke has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bogachan Sahin | Conditions: Acute Stroke, Visual Field Loss | Phase 2 | Status: TERMINATED | Results posted: 2021-10-13